Optima Health PLC Director / PDMR Shareholding

RNS Number : 8233Q

Optima Health PLC

19 December 2024

 

19 December 2024

 

 

Optima Health plc

("Optima Health" or the "Company")

Director / PDMR Shareholding

 

Optima Health plc (AIM: OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, announces that it was notified on 19 December 2024, Heidi Giles, (Chief Financial Officer of the Company) purchased 13,500 ordinary shares of £0.01 in the Company ("Ordinary Shares") at a price of 147.4 pence per share.

Following this, Heidi Giles holds an in interest 83,228 Ordinary Shares, representing approximately 0.09% of the current issued share capital. 

Contacts:

Optima Health
Jonathan Thomas, CEO Heidi Giles, CFO	[phone] [e-mail]
Nominated Adviser and Corporate Broker
Panmure Liberum Limited	[phone]
Emma Earl / Will Goode/ Mark Rogers / Rupert Dearden
UK Financial PR Adviser ICR Healthcare Mary-Jane Elliott / Angela Gray / Chris Welsh	[e-mail]

 

About Optima Health

 

Optima Health is the UK's leading provider of occupational health and wellbeing services, directly influencing and improving people's lives for 25 years. Optima Health's incredible team of professionals quickly and effectively encapsulate client's needs, supporting organisations of all shapes and sizes. Through tailored solutions and innovative systems, Optima Health offers unparalleled clinical expertise to its clients. These solutions ensure that processes are simple and allow its clients to spend more time focusing on their employees driving a healthy, high-performing workplace. For more information visit www.optima health.co.uk

 

 

 

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Heidi Giles
2	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Optima Health plc
b)	LEI	213800TOPWJSRCW4ON08
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	GB00BRSCY602
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)
			Purchase Price	Volume
			147.4 pence	13,500
d)	Aggregated information
	- Aggregated volume	n/a
	- Price
e)	Date of the transaction	19 December 2024
f)	Place of the transaction	London Stock Exchange, AIM Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHBLBDDSXBDGSC